SENS-E: Development and testing of a screening instrument for the detection of sensory processing sensitivity



 Liffler P. (1), Fölster-Holst R. (2), Gieler U. (3), Peters E.M.J. (4)


 (1) Kinderfachklinik Bellevue, Fehmarn


(2) Universitätsklinikum Schleswig-Holstein, Campus Kiel, Dermatologie, Venerologie und Allergologie, Kiel


(3) Klinik für Dermatologie und Allergologie und Klinik für Psychosomatik und Psychotherapie, Psychosomatische Dermatologie, Justus-Liebig-Universität Gießen


(4) Klinik für Psychosomatik und Psychotherapie, Psychoneuroimmunologie Labor, Justus-Liebig-Universität, Gießen

Short title: Screening of the Sensory processing sensitivity (SPS)

Objectives: Current Measurement of sensory processing sensitivity (SPS) showed shortcomings during a study of its relationship to atopy (Liffler et al. 2019). Aim was the development of a SPS screening to facilitate clinical diagnostics and future research.


Methods: The sample was conducted via direct and onlinesurvey (N=305) followed by dividing into an atopic (AP) and non-atopic (NAP) group according to biographical data of respondents. With group comparisons the 30-item base version was gradually reduced to a 16-item screening procedure, which was finally tested by comparing subsamples. 


Results: AP and NAP differed significantly in all 16 items. These depicted the construct without losing internal consistency. Subsample comparisons showed good construct validity. Logistic Regression Analysis showed significant dependence of atopic diseases and frequent mental disorders on the level of the SPS.


Conclusions: The 16-item SENS-E test showed good psychometric properties. This could facilitate treatment planning in psychosomatic medicine, psychotherapy, and cohort studies



Sensory processing sensitivity - SENS-E-screening procedures - risk groups